NCT05963659

Brief Summary

Alcohol use is increasingly prevalent in modern society and is known to cause cognitive impairment and dysregulation of inflammatory responses. In the present study, the investigators want to perform a randomised controlled trials to test whether nitrate could change the oral microbiota and benefit the cognitive impairment in alcohol dependence patients. The investigators survey the oral bacterial communities in saliva samples of 70 alcohol dependent patients following 14 days of dietary inorganic nitrate (nitrate-rich beetroot juice, \~750 mg NO3- /d) and placebo (nitrate-depleted beetroot juice, \~1 mg NO3- /d) supplementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 10, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 7, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 7, 2024

Completed
Last Updated

June 3, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

June 30, 2023

Last Update Submit

May 28, 2025

Conditions

Keywords

nitrateoral microbiotaalcohol dependence

Outcome Measures

Primary Outcomes (2)

  • Changes of Delayed Match to Sample Percent Correct (all delays) from baseline to post-intervention

    Test by DMS-PCAD (Delayed Match to Sample Percent Correct , all delays)

    baseline and post-intervention(two weeks after baseline test)

  • Changes of Spatial Working Memory Between Errors from baseline to post-intervention

    Test by SWM-BE (The Spatial Working Memory Between Errors )

    baseline and post-intervention(two weeks after baseline test)

Secondary Outcomes (20)

  • Changes of oral microbiota from baseline to post-intervention

    baseline and post-intervention(two weeks after baseline test)

  • Changes of gut microbiota from baseline to post-intervention

    baseline and post-intervention(two weeks after baseline test)

  • Changes of Delayed Match to Sample Percent Correct (0 seconds delay) from baseline to post-intervention

    baseline and post-intervention(two weeks after baseline test)

  • Changes of Delayed Match to Sample Percent Correct (4 seconds delay) from baseline to post-intervention

    baseline and post-intervention(two weeks after baseline test)

  • Changes of Delayed Match to Sample Percent Correct (12 seconds delay) from baseline to post-intervention

    baseline and post-intervention(two weeks after baseline test)

  • +15 more secondary outcomes

Other Outcomes (7)

  • Systolic and diastolic blood pressure

    baseline and post-intervention (two weeks after baseline test)

  • Cytokine Tumor Necrosis Factor-a in serum

    baseline and post-intervention(two weeks after baseline test)

  • The blood biochemical related parameters includes liver enzymes (alanine aminotransferase and aspartate aminotransferase)

    baseline and post-intervention (two weeks after baseline test)

  • +4 more other outcomes

Study Arms (2)

Group N

EXPERIMENTAL
Dietary Supplement: nitrate-rich beetroot juice

Group P

PLACEBO COMPARATOR
Dietary Supplement: nitrate-depleted beetroot juice

Interventions

nitrate-rich beetroot juiceDIETARY_SUPPLEMENT

nitrate-rich beetroot juice, \~750 mg NO3- /d

Group N

nitrate-depleted beetroot juice, \~1 mg NO3- /d

Group P

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Han nationality
  • Montreal Cognitive Assessment(MoCA) score \>11
  • Diagnosis of alcohol dependence

You may not qualify if:

  • Past or current infectious disease
  • Past or current heart, brain, liver, kidney, and other severe diseases
  • Past or current metabolic diseases that can lead to abnormalities of the immune system, such as obesity (Body Mass Index \> 30 kg/m2), diabetes, or rheumatoid arthritis
  • Past or current neurodegenerative diseases, such as Parkinson's disease
  • Use of steroidal and non-steroidal anti-inflammatory drugs, antibiotics, antioxidants, and immunosuppressive agents within two months of enrollment
  • Use of probiotics and probiotics every day for the first two months before enrollment
  • Previous or current DSM-IV diagnosis of schizophrenia, depression, anxiety disorder, bipolar disorder, mental retardation, dementia (excluding mild cognitive impairment, MCI), or substance dependence other than alcohol and nicotine
  • Irregular eating habits that affect the oral flora (except alcohol) in the previous two months
  • Current oral disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anhui mental health center

Hefei, Anhui, 230022, China

Location

MeSH Terms

Conditions

Congenital MicrotiaAlcoholism

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Hongqiang Sun

    Peking University Sixth Hospital

    PRINCIPAL INVESTIGATOR
  • Liangjun Pang

    Anhui mental health central

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor,Director

Study Record Dates

First Submitted

June 30, 2023

First Posted

July 27, 2023

Study Start

September 10, 2023

Primary Completion

August 7, 2024

Study Completion

August 7, 2024

Last Updated

June 3, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations